Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Number of holders
-
456
-
Total 13F shares, excl. options
-
18,457,660
-
Shares change
-
-125,570
-
Total reported value, excl. options
-
$6,613,055,542
-
Value change
-
-$70,137,676
-
Put/Call ratio
-
109%
-
Number of buys
-
192
-
Number of sells
-
234
-
Price
-
$358.45
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2023
As of 30 Sep 2023 BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) had 456 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,457,660 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Veritas Asset Management LLP, BROWN ADVISORY INC, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, ALLIANCEBERNSTEIN L.P., and MILLENNIUM MANAGEMENT LLC.
This table shows 465 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.